Gamma Investing LLC Harmony Biosciences Holdings, Inc. Transaction History
Gamma Investing LLC
- $1.58 Trillion
- Q2 2025
A detailed history of Gamma Investing LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 1,705 shares of HRMY stock, worth $60,476. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,705
Previous 2,929
41.79%
Holding current value
$60,476
Previous $97.2 Million
44.58%
% of portfolio
0.0%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding HRMY
# of Institutions
288Shares Held
46.2MCall Options Held
316KPut Options Held
69.9K-
Valor Management LLC Chicago, IL6.62MShares$235 Million88.32% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$207 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$181 Million0.0% of portfolio
-
State Street Corp Boston, MA1.63MShares$57.8 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.58MShares$56.1 Million0.01% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $2.1B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...